.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The updated Rashtriya Bal Swasthya Karyakram, known as RBSK 2.0 disability screening, faces significant criticism from a national collective of doctors. Specifically, healthcare professionals from the Doctors with Disabilities group argue that the program fails to address disability as a core priority. Consequently, this policy gap could leave millions of children without early diagnosis and care. While the program expands coverage, it arguably ignores legal mandates for comprehensive inclusion.
The 124-page guideline for the program reportedly omits the specific term \"disability.\" This exclusion raises serious concerns regarding compliance with the Rights of Persons with Disabilities (RPwD) Act, 2016. Furthermore, experts note that conditions like thalassemia, sickle cell disease, and haemophilia remain outside the core screening framework. Therefore, doctors urge the Union Health Ministry to integrate all specified disabilities under the law. Integrating these conditions into rural health settings is both feasible and low-cost.
Public health experts highlight the lack of disability indicators in program monitoring. Additionally, the current framework does not link with the Unique Disability ID (UDID) system. This disconnection weakens accountability and prevents effective tracking of child health outcomes. As a result, global bodies like the World Health Assembly continue to push for universal newborn screening. Thus, involving persons with disabilities in program design remains a critical next step for the government.
Q1: Why is the Doctors with Disabilities collective criticizing the new RBSK 2.0 guidelines?
The collective argues that the 124-page document omits the term \"disability\" entirely. This failure to align with the RPwD Act 2016 could result in millions of children being overlooked during screenings.
Q2: What specific conditions are experts concerned about in RBSK 2.0?
Experts highlight that blood disorders like thalassemia and sickle cell disease are not integrated into the core screening framework. Although India has a high burden of these conditions, they are currently managed through separate, parallel programs.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Experts criticize RBSK 2.0 for failing to include disability as a core priority, potentially missing millions of children during early screening....
4 months ago
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
